Vycor Medical Inc financial data

Symbol
VYCO on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
951 Broken Sound Parkway, Suite 320, Boca Raton,, FL
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 14.9 % -0.54%
Quick Ratio 5.01 % -15.5%
Debt-to-equity -129 % +0.82%
Return On Equity 5.51 % +81.4%
Return On Assets -19.2 % -88.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 33.4M shares +2.28%
Common Stock, Shares, Outstanding 33.4M shares +2.28%
Entity Public Float 1.17M USD -29.6%
Common Stock, Value, Issued 3.35K USD +2.29%
Weighted Average Number of Shares Outstanding, Basic 32.9M shares +0.84%
Weighted Average Number of Shares Outstanding, Diluted 32.6M shares -12.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.44M USD +1.32%
Research and Development Expense 6.43K USD -11.4%
Operating Income (Loss) -92.5K USD -809%
Nonoperating Income (Expense) -97.7K USD +4.27%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -190K USD -114%
Net Income (Loss) Attributable to Parent -194K USD -108%
Earnings Per Share, Basic -0.02 USD/shares -100%
Earnings Per Share, Diluted -0.02 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 158K USD +128%
Accounts Receivable, after Allowance for Credit Loss, Current 239K USD -6.49%
Inventory, Net 188K USD -8.36%
Assets, Current 743K USD +18.8%
Property, Plant and Equipment, Net 210K USD -19.8%
Operating Lease, Right-of-Use Asset 115K USD -28.3%
Assets 1.07M USD +1.91%
Accounts Payable, Current 151K USD +32.8%
Liabilities, Current 4.55M USD +12.9%
Operating Lease, Liability, Noncurrent 64.7K USD -42.2%
Liabilities 4.76M USD +11%
Accumulated Other Comprehensive Income (Loss), Net of Tax 128K USD 0%
Retained Earnings (Accumulated Deficit) -33.2M USD -1.58%
Stockholders' Equity Attributable to Parent -3.68M USD -14%
Liabilities and Equity 1.07M USD +1.91%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.89K USD -92.3%
Net Cash Provided by (Used in) Financing Activities -16K USD -13%
Net Cash Provided by (Used in) Investing Activities 662 USD +130%
Common Stock, Shares Authorized 55M shares 0%
Common Stock, Shares, Issued 33.5M shares +2.27%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -13.4K USD -225%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.37K USD -2.14%
Deferred Tax Assets, Valuation Allowance 4.66M USD -0.24%
Operating Lease, Liability 112K USD -28.6%
Depreciation 15.6K USD +1.73%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -194K USD -108%
Property, Plant and Equipment, Gross 1.4M USD +0.68%
Operating Lease, Liability, Current 47.2K USD +5.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 52.1K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 51.6K USD +50%
Lessee, Operating Lease, Liability, to be Paid, Year Three 53.7K USD
Preferred Stock, Shares Issued 270K shares 0%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 29.4M USD +0.23%
Preferred Stock, Shares Outstanding 270K shares 0%
Share-based Payment Arrangement, Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%